Ignite Creation Date:
2024-05-05 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00228319
Status:
COMPLETED
Last Update Posted:
2018-06-19
First Post:
2005-09-23
Brief Title:
Treatment of Newly Diagnosed Ovarian Cancer With Antioxidants
Sponsor:
Jeanne Drisko MD CNS FACN
Organization:
University of Kansas Medical Center
Study Overview
Official Title:
Antioxidant Effects on the Outcome of Ovarian Cancer
Status:
COMPLETED
Status Verified Date:
2018-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to try and understand if there is added benefit or increased harm when antioxidant nutritional supplements are added to traditional chemotherapy in the treatment of ovarian cancer
Detailed Description:
The subjects are randomized to 2 study groups Group 1 receives standard chemotherapy prescribed by the cancer doctor carboplatin and paclitaxelwith a possible choice to extend chemotherapy for up to an additional 12 months
Group 2 receives standard chemotherapy in the same manner as group 1 In addition they receive 12 months of oral or IV nutritional supplements
Group 2 receives standard chemotherapy in the same manner as group 1 In addition they receive 12 months of oral or IV nutritional supplements
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| G-01-029 | None | None | None |